Cytel to acquire SDS Life Science and SDS MedteQ

The move will add new global talent to Cytel’s Strategic Consulting group

Celanese support the sustained-release drug delivery market

Availability of pharmaceutical-grade materials with broad API compatibility key to advancing drug delivery solutions

Dupixent Phase 3 data showed significant histological remission of eosinophilic esophagitis

68% of children on a higher dose of Dupixent achieved histological disease remission at week 16

Merck recognized on Fortune’s 2022 change the World List

This recognition marks the third time in five years that Merck has been included on Fortune’s Change the World list.

Merck announces positive top-line results from Phase 3 Stellar Trail evaluating Sotatercept for the treatment of PAH

Sotatercept demonstrated significant improvement in exercise capacity and key secondary outcome measures compared to placebo when added to background therapy

India committed to promote green and climate resilient healthcare facilities: Dr Pawar

Cumulatively, almost 75% of the health centres in the country have been electrified with a cumulative solar capacity of 3.5 MW

Pfizer announces positive topline results from Phase 3 TALAPRO-2 trial

Study achieves primary endpoint of radiographic progression-free survival

ICON selected by BARDA to conduct anthrax vaccine clinical trial

This clinical study will inform operational logistics and use of AV7909 should an anthrax emergency occur.

AGC begins study to expand its Bio-CDMO capability in Japan

Philips shareholders appoint Roy Jakobs as next President and CEO

Roy is the right successor to lead Philips’ efforts to help improve the health and well-being of people globally